Your browser doesn't support javascript.
loading
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
Walker, Lauren E; FitzGerald, Richard; Saunders, Geoffrey; Lyon, Rebecca; Fisher, Michael; Martin, Karen; Eberhart, Izabela; Woods, Christie; Ewings, Sean; Hale, Colin; Rajoli, Rajith K R; Else, Laura; Dilly-Penchala, Sujan; Amara, Alieu; Lalloo, David G; Jacobs, Michael; Pertinez, Henry; Hatchard, Parys; Waugh, Robert; Lawrence, Megan; Johnson, Lucy; Fines, Keira; Reynolds, Helen; Rowland, Timothy; Crook, Rebecca; Okenyi, Emmanuel; Byrne, Kelly; Mozgunov, Pavel; Jaki, Thomas; Khoo, Saye; Owen, Andrew; Griffiths, Gareth; Fletcher, Thomas E.
Afiliación
  • Walker LE; University of Liverpool, Liverpool, UK.
  • FitzGerald R; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Saunders G; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Lyon R; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Fisher M; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Martin K; University of Liverpool, Liverpool, UK.
  • Eberhart I; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Woods C; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Ewings S; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Hale C; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Rajoli RKR; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Else L; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Dilly-Penchala S; University of Liverpool, Liverpool, UK.
  • Amara A; University of Liverpool, Liverpool, UK.
  • Lalloo DG; University of Liverpool, Liverpool, UK.
  • Jacobs M; University of Liverpool, Liverpool, UK.
  • Pertinez H; Liverpool School of Tropical Medicine, Liverpool, UK.
  • Hatchard P; Liverpool School of Tropical Medicine, Liverpool, UK.
  • Waugh R; University of Liverpool, Liverpool, UK.
  • Lawrence M; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Johnson L; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Fines K; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Reynolds H; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Rowland T; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Crook R; University of Liverpool, Liverpool, UK.
  • Okenyi E; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Byrne K; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Mozgunov P; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Jaki T; Liverpool School of Tropical Medicine, Liverpool, UK.
  • Khoo S; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Owen A; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Griffiths G; University of Liverpool, Liverpool, UK.
  • Fletcher TE; University of Liverpool, Liverpool, UK.
Clin Pharmacol Ther ; 111(3): 585-594, 2022 03.
Article en En | MEDLINE | ID: mdl-34699618
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Tiazoles / Nitrocompuestos Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Tiazoles / Nitrocompuestos Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido